Nuformix plc (LON:NFX)
London · Delayed Price · Currency is GBP · Price in GBX 0.1410
+0.0060 (4.44%)
Aug 14, 2026, 4:35 PM GMT
Nuformix Balance Sheet
Financials in millions GBP. Fiscal year is October - September.
Millions GBP. Fiscal year is Oct - Sep.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 0.93 | 0.1 | 0.02 | 0.2 | 0.26 | 0.46 |
Cash & Short-Term Investments | 0.93 | 0.1 | 0.02 | 0.2 | 0.26 | 0.46 |
Cash Growth | 850.13% | 382.68% | -90.02% | -21.87% | -44.14% | -72.21% |
Accounts Receivable | 0.04 | - | - | - | - | - |
Other Receivables | 0.01 | 0.02 | 0.02 | 0.12 | 0.13 | 0.33 |
Receivables | 0.05 | 0.02 | 0.02 | 0.12 | 0.13 | 0.33 |
Prepaid Expenses | - | 0.02 | 0.02 | 0.02 | - | 0.03 |
Other Current Assets | - | 0 | - | - | - | - |
Total Current Assets | 0.98 | 0.14 | 0.06 | 0.34 | 0.39 | 0.82 |
Property, Plant & Equipment | - | - | - | - | - | 0 |
Goodwill | 0.88 | 0.88 | 0.88 | 4.02 | 4.02 | 4.02 |
Other Intangible Assets | - | - | 0.03 | 0.06 | 0.09 | 0.13 |
Other Long-Term Assets | - | -0 | - | - | - | - |
Total Assets | 1.86 | 1.02 | 0.97 | 4.42 | 4.5 | 4.98 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Accounts Payable | 0.23 | 0.05 | 0.03 | 0.07 | 0.27 | 0.01 |
Accrued Expenses | - | 0.22 | 0.22 | 0.15 | - | 0.23 |
Total Current Liabilities | 0.23 | 0.26 | 0.25 | 0.22 | 0.27 | 0.24 |
Total Liabilities | 0.23 | 0.26 | 0.25 | 0.22 | 0.27 | 0.24 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Common Stock | 1.71 | 1.41 | 0.82 | 0.74 | 0.71 | 0.62 |
Additional Paid-In Capital | 7.76 | 6.84 | 6.73 | 6.66 | 6.64 | 6.5 |
Retained Earnings | -10.81 | -10.46 | -9.84 | -6.21 | -8.11 | -7.35 |
Comprehensive Income & Other | 2.97 | 2.97 | 3.01 | 3 | 4.99 | 4.97 |
Shareholders' Equity | 1.64 | 0.75 | 0.72 | 4.2 | 4.23 | 4.74 |
Total Liabilities & Equity | 1.86 | 1.02 | 0.97 | 4.42 | 4.5 | 4.98 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Cash (Debt) | 0.93 | 0.1 | 0.02 | 0.2 | 0.26 | 0.46 |
Net Cash Growth | 850.13% | 382.68% | -90.02% | -21.87% | -44.14% | -72.21% |
Net Cash Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Filing Date Shares Outstanding | 2,610 | 1,996 | 819.31 | 744.31 | 709.31 | 709.31 |
Total Common Shares Outstanding | 2,610 | 1,996 | 819.31 | 744.31 | 709.31 | 615.61 |
Working Capital | 0.75 | -0.13 | -0.2 | 0.11 | 0.11 | 0.59 |
Book Value Per Share | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 |
Tangible Book Value | 0.75 | -0.13 | -0.2 | 0.11 | 0.11 | 0.59 |
Tangible Book Value Per Share | 0.00 | -0.00 | -0.00 | 0.00 | 0.00 | 0.00 |
Machinery | - | - | - | - | - | 0 |